Click for best price
Oral Live Cholera Vaccines Market Size, Share 2024
| Market size in 2023 |
US$ 80 million
|
Forecast Market size by 2030 |
US$ 138.7 million
|
| Growth Rate |
CAGR of 7.4% |
Number of Pages |
94 Pages |
The global Oral Live Cholera Vaccines market was valued at US$ 80 million in 2023 and is projected to reach US$ 138.7 million by 2030, at a CAGR of 7.4% during the forecast period.
This research report provides a comprehensive analysis of the Oral Live Cholera Vaccines market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Oral Live Cholera Vaccines market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Oral Live Cholera Vaccines, challenges faced by the industry, and potential opportunities for market players.
The global Oral Live Cholera Vaccines market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Oral Live Cholera Vaccines market presents opportunities for various stakeholders, including Prevention, Emergency Response. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Oral Live Cholera Vaccines market. Additionally, the growing consumer demand present avenues for market expansion.
Factors such as increasing incidence of cholera outbreaks, rising awareness about the disease and its prevention, and government initiatives to control cholera are driving market growth. Oral live cholera vaccines offer advantages such as ease of administration, cost-effectiveness, and potential for herd immunity. The market is characterized by the presence of both established pharmaceutical companies and emerging players. However, challenges such as vaccine storage and distribution requirements, limited accessibility in resource-constrained regions, and the need for cold chain maintenance may pose obstacles to market expansion.
Key Features:
The research report on the Oral Live Cholera Vaccines market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Oral Live Cholera Vaccines market.
Market Overview: The report provides a comprehensive overview of the Oral Live Cholera Vaccines market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Euvichol- Plus, DUKORAL), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Oral Live Cholera Vaccines market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Oral Live Cholera Vaccines market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Oral Live Cholera Vaccines market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Oral Live Cholera Vaccines market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Oral Live Cholera Vaccines market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Oral Live Cholera Vaccines market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Oral Live Cholera Vaccines, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Oral Live Cholera Vaccines market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Oral Live Cholera Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Euvichol- Plus
- DUKORAL
- Shanchol
- Others
Market segment by Application
- Prevention
- Emergency Response
Global Oral Live Cholera Vaccines Market Segment Percentages, By Region and Country, 2023 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Major players covered
- PaxVax
- Sanofi
- Valneva
- EuBiologics
- Shanghai United Cell Biotechnology
- Vabiotech
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oral Live Cholera Vaccines, market overview.
Chapter 2: Global Oral Live Cholera Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Oral Live Cholera Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oral Live Cholera Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Oral Live Cholera Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Oral Live Cholera Vaccines Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 80 million
|
| Forecast Market size by 2030 |
US$ 138.7 million
|
| Growth Rate |
CAGR of 7.4% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
94 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Oral Live Cholera Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oral Live Cholera Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oral Live Cholera Vaccines Overall Market Size
2.1 Global Oral Live Cholera Vaccines Market Size: 2023 VS 2030
2.2 Global Oral Live Cholera Vaccines Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Oral Live Cholera Vaccines Sales: 2019-2030
3 Company Landscape
3.1 Top Oral Live Cholera Vaccines Players in Global Market
3.2 Top Global Oral Live Cholera Vaccines Companies Ranked by Revenue
3.3 Global Oral Live Cholera Vaccines Revenue by Companies
3.4 Global Oral Live Cholera Vaccines Sales by Companies
3.5 Global Oral Live Cholera Vaccines Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Oral Live Cholera Vaccines Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Oral Live Cholera Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Oral Live Cholera Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Oral Live Cholera Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Oral Live Cholera Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Oral Live Cholera Vaccines Market Size Markets, 2023 & 2030
4.1.2 Euvichol- Plus
4.1.3 DUKORAL
4.1.4 Shanchol
4.1.5 Others
4.2 By Type - Global Oral Live Cholera Vaccines Revenue & Forecasts
4.2.1 By Type - Global Oral Live Cholera Vaccines Revenue, 2019-2024
4.2.2 By Type - Global Oral Live Cholera Vaccines Revenue, 2025-2030
4.2.3 By Type - Global Oral Live Cholera Vaccines Revenue Market Share, 2019-2030
4.3 By Type - Global Oral Live Cholera Vaccines Sales & Forecasts
4.3.1 By Type - Global Oral Live Cholera Vaccines Sales, 2019-2024
4.3.2 By Type - Global Oral Live Cholera Vaccines Sales, 2025-2030
4.3.3 By Type - Global Oral Live Cholera Vaccines Sales Market Share, 2019-2030
4.4 By Type - Global Oral Live Cholera Vaccines Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Oral Live Cholera Vaccines Market Size, 2023 & 2030
5.1.2 Prevention
5.1.3 Emergency Response
5.2 By Application - Global Oral Live Cholera Vaccines Revenue & Forecasts
5.2.1 By Application - Global Oral Live Cholera Vaccines Revenue, 2019-2024
5.2.2 By Application - Global Oral Live Cholera Vaccines Revenue, 2025-2030
5.2.3 By Application - Global Oral Live Cholera Vaccines Revenue Market Share, 2019-2030
5.3 By Application - Global Oral Live Cholera Vaccines Sales & Forecasts
5.3.1 By Application - Global Oral Live Cholera Vaccines Sales, 2019-2024
5.3.2 By Application - Global Oral Live Cholera Vaccines Sales, 2025-2030
5.3.3 By Application - Global Oral Live Cholera Vaccines Sales Market Share, 2019-2030
5.4 By Application - Global Oral Live Cholera Vaccines Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Oral Live Cholera Vaccines Market Size, 2023 & 2030
6.2 By Region - Global Oral Live Cholera Vaccines Revenue & Forecasts
6.2.1 By Region - Global Oral Live Cholera Vaccines Revenue, 2019-2024
6.2.2 By Region - Global Oral Live Cholera Vaccines Revenue, 2025-2030
6.2.3 By Region - Global Oral Live Cholera Vaccines Revenue Market Share, 2019-2030
6.3 By Region - Global Oral Live Cholera Vaccines Sales & Forecasts
6.3.1 By Region - Global Oral Live Cholera Vaccines Sales, 2019-2024
6.3.2 By Region - Global Oral Live Cholera Vaccines Sales, 2025-2030
6.3.3 By Region - Global Oral Live Cholera Vaccines Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Oral Live Cholera Vaccines Revenue, 2019-2030
6.4.2 By Country - North America Oral Live Cholera Vaccines Sales, 2019-2030
6.4.3 US Oral Live Cholera Vaccines Market Size, 2019-2030
6.4.4 Canada Oral Live Cholera Vaccines Market Size, 2019-2030
6.4.5 Mexico Oral Live Cholera Vaccines Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Oral Live Cholera Vaccines Revenue, 2019-2030
6.5.2 By Country - Europe Oral Live Cholera Vaccines Sales, 2019-2030
6.5.3 Germany Oral Live Cholera Vaccines Market Size, 2019-2030
6.5.4 France Oral Live Cholera Vaccines Market Size, 2019-2030
6.5.5 U.K. Oral Live Cholera Vaccines Market Size, 2019-2030
6.5.6 Italy Oral Live Cholera Vaccines Market Size, 2019-2030
6.5.7 Russia Oral Live Cholera Vaccines Market Size, 2019-2030
6.5.8 Nordic Countries Oral Live Cholera Vaccines Market Size, 2019-2030
6.5.9 Benelux Oral Live Cholera Vaccines Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Oral Live Cholera Vaccines Revenue, 2019-2030
6.6.2 By Region - Asia Oral Live Cholera Vaccines Sales, 2019-2030
6.6.3 China Oral Live Cholera Vaccines Market Size, 2019-2030
6.6.4 Japan Oral Live Cholera Vaccines Market Size, 2019-2030
6.6.5 South Korea Oral Live Cholera Vaccines Market Size, 2019-2030
6.6.6 Southeast Asia Oral Live Cholera Vaccines Market Size, 2019-2030
6.6.7 India Oral Live Cholera Vaccines Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Oral Live Cholera Vaccines Revenue, 2019-2030
6.7.2 By Country - South America Oral Live Cholera Vaccines Sales, 2019-2030
6.7.3 Brazil Oral Live Cholera Vaccines Market Size, 2019-2030
6.7.4 Argentina Oral Live Cholera Vaccines Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Oral Live Cholera Vaccines Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Oral Live Cholera Vaccines Sales, 2019-2030
6.8.3 Turkey Oral Live Cholera Vaccines Market Size, 2019-2030
6.8.4 Israel Oral Live Cholera Vaccines Market Size, 2019-2030
6.8.5 Saudi Arabia Oral Live Cholera Vaccines Market Size, 2019-2030
6.8.6 UAE Oral Live Cholera Vaccines Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 PaxVax
7.1.1 PaxVax Company Summary
7.1.2 PaxVax Business Overview
7.1.3 PaxVax Oral Live Cholera Vaccines Major Product Offerings
7.1.4 PaxVax Oral Live Cholera Vaccines Sales and Revenue in Global (2019-2024)
7.1.5 PaxVax Key News & Latest Developments
7.2 Sanofi
7.2.1 Sanofi Company Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Oral Live Cholera Vaccines Major Product Offerings
7.2.4 Sanofi Oral Live Cholera Vaccines Sales and Revenue in Global (2019-2024)
7.2.5 Sanofi Key News & Latest Developments
7.3 Valneva
7.3.1 Valneva Company Summary
7.3.2 Valneva Business Overview
7.3.3 Valneva Oral Live Cholera Vaccines Major Product Offerings
7.3.4 Valneva Oral Live Cholera Vaccines Sales and Revenue in Global (2019-2024)
7.3.5 Valneva Key News & Latest Developments
7.4 EuBiologics
7.4.1 EuBiologics Company Summary
7.4.2 EuBiologics Business Overview
7.4.3 EuBiologics Oral Live Cholera Vaccines Major Product Offerings
7.4.4 EuBiologics Oral Live Cholera Vaccines Sales and Revenue in Global (2019-2024)
7.4.5 EuBiologics Key News & Latest Developments
7.5 Shanghai United Cell Biotechnology
7.5.1 Shanghai United Cell Biotechnology Company Summary
7.5.2 Shanghai United Cell Biotechnology Business Overview
7.5.3 Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Major Product Offerings
7.5.4 Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Sales and Revenue in Global (2019-2024)
7.5.5 Shanghai United Cell Biotechnology Key News & Latest Developments
7.6 Vabiotech
7.6.1 Vabiotech Company Summary
7.6.2 Vabiotech Business Overview
7.6.3 Vabiotech Oral Live Cholera Vaccines Major Product Offerings
7.6.4 Vabiotech Oral Live Cholera Vaccines Sales and Revenue in Global (2019-2024)
7.6.5 Vabiotech Key News & Latest Developments
8 Global Oral Live Cholera Vaccines Production Capacity, Analysis
8.1 Global Oral Live Cholera Vaccines Production Capacity, 2019-2030
8.2 Oral Live Cholera Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Oral Live Cholera Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Oral Live Cholera Vaccines Supply Chain Analysis
10.1 Oral Live Cholera Vaccines Industry Value Chain
10.2 Oral Live Cholera Vaccines Upstream Market
10.3 Oral Live Cholera Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Oral Live Cholera Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Oral Live Cholera Vaccines in Global Market
Table 2. Top Oral Live Cholera Vaccines Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Oral Live Cholera Vaccines Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Oral Live Cholera Vaccines Revenue Share by Companies, 2019-2024
Table 5. Global Oral Live Cholera Vaccines Sales by Companies, (K Units), 2019-2024
Table 6. Global Oral Live Cholera Vaccines Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Oral Live Cholera Vaccines Price (2019-2024) & (USD/Unit)
Table 8. Global Manufacturers Oral Live Cholera Vaccines Product Type
Table 9. List of Global Tier 1 Oral Live Cholera Vaccines Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oral Live Cholera Vaccines Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Oral Live Cholera Vaccines Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Oral Live Cholera Vaccines Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Oral Live Cholera Vaccines Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Oral Live Cholera Vaccines Sales (K Units), 2019-2024
Table 15. By Type - Global Oral Live Cholera Vaccines Sales (K Units), 2025-2030
Table 16. By Application ? Global Oral Live Cholera Vaccines Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Oral Live Cholera Vaccines Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Oral Live Cholera Vaccines Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Oral Live Cholera Vaccines Sales (K Units), 2019-2024
Table 20. By Application - Global Oral Live Cholera Vaccines Sales (K Units), 2025-2030
Table 21. By Region ? Global Oral Live Cholera Vaccines Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Oral Live Cholera Vaccines Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Oral Live Cholera Vaccines Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Oral Live Cholera Vaccines Sales (K Units), 2019-2024
Table 25. By Region - Global Oral Live Cholera Vaccines Sales (K Units), 2025-2030
Table 26. By Country - North America Oral Live Cholera Vaccines Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Oral Live Cholera Vaccines Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Oral Live Cholera Vaccines Sales, (K Units), 2019-2024
Table 29. By Country - North America Oral Live Cholera Vaccines Sales, (K Units), 2025-2030
Table 30. By Country - Europe Oral Live Cholera Vaccines Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Oral Live Cholera Vaccines Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Oral Live Cholera Vaccines Sales, (K Units), 2019-2024
Table 33. By Country - Europe Oral Live Cholera Vaccines Sales, (K Units), 2025-2030
Table 34. By Region - Asia Oral Live Cholera Vaccines Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Oral Live Cholera Vaccines Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Oral Live Cholera Vaccines Sales, (K Units), 2019-2024
Table 37. By Region - Asia Oral Live Cholera Vaccines Sales, (K Units), 2025-2030
Table 38. By Country - South America Oral Live Cholera Vaccines Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Oral Live Cholera Vaccines Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Oral Live Cholera Vaccines Sales, (K Units), 2019-2024
Table 41. By Country - South America Oral Live Cholera Vaccines Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Oral Live Cholera Vaccines Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Oral Live Cholera Vaccines Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Oral Live Cholera Vaccines Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Oral Live Cholera Vaccines Sales, (K Units), 2025-2030
Table 46. PaxVax Company Summary
Table 47. PaxVax Oral Live Cholera Vaccines Product Offerings
Table 48. PaxVax Oral Live Cholera Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 49. PaxVax Key News & Latest Developments
Table 50. Sanofi Company Summary
Table 51. Sanofi Oral Live Cholera Vaccines Product Offerings
Table 52. Sanofi Oral Live Cholera Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 53. Sanofi Key News & Latest Developments
Table 54. Valneva Company Summary
Table 55. Valneva Oral Live Cholera Vaccines Product Offerings
Table 56. Valneva Oral Live Cholera Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 57. Valneva Key News & Latest Developments
Table 58. EuBiologics Company Summary
Table 59. EuBiologics Oral Live Cholera Vaccines Product Offerings
Table 60. EuBiologics Oral Live Cholera Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 61. EuBiologics Key News & Latest Developments
Table 62. Shanghai United Cell Biotechnology Company Summary
Table 63. Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Product Offerings
Table 64. Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 65. Shanghai United Cell Biotechnology Key News & Latest Developments
Table 66. Vabiotech Company Summary
Table 67. Vabiotech Oral Live Cholera Vaccines Product Offerings
Table 68. Vabiotech Oral Live Cholera Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 69. Vabiotech Key News & Latest Developments
Table 70. Oral Live Cholera Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2022-2024 (K Units)
Table 71. Global Oral Live Cholera Vaccines Capacity Market Share of Key Manufacturers, 2022-2024
Table 72. Global Oral Live Cholera Vaccines Production by Region, 2019-2024 (K Units)
Table 73. Global Oral Live Cholera Vaccines Production by Region, 2025-2030 (K Units)
Table 74. Oral Live Cholera Vaccines Market Opportunities & Trends in Global Market
Table 75. Oral Live Cholera Vaccines Market Drivers in Global Market
Table 76. Oral Live Cholera Vaccines Market Restraints in Global Market
Table 77. Oral Live Cholera Vaccines Raw Materials
Table 78. Oral Live Cholera Vaccines Raw Materials Suppliers in Global Market
Table 79. Typical Oral Live Cholera Vaccines Downstream
Table 80. Oral Live Cholera Vaccines Downstream Clients in Global Market
Table 81. Oral Live Cholera Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Oral Live Cholera Vaccines Segment by Type in 2023
Figure 2. Oral Live Cholera Vaccines Segment by Application in 2023
Figure 3. Global Oral Live Cholera Vaccines Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Oral Live Cholera Vaccines Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Oral Live Cholera Vaccines Revenue, 2019-2030 (US$, Mn)
Figure 7. Oral Live Cholera Vaccines Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Oral Live Cholera Vaccines Revenue in 2023
Figure 9. By Type - Global Oral Live Cholera Vaccines Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Oral Live Cholera Vaccines Revenue Market Share, 2019-2030
Figure 11. By Type - Global Oral Live Cholera Vaccines Sales Market Share, 2019-2030
Figure 12. By Type - Global Oral Live Cholera Vaccines Price (USD/Unit), 2019-2030
Figure 13. By Application - Global Oral Live Cholera Vaccines Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Oral Live Cholera Vaccines Revenue Market Share, 2019-2030
Figure 15. By Application - Global Oral Live Cholera Vaccines Sales Market Share, 2019-2030
Figure 16. By Application - Global Oral Live Cholera Vaccines Price (USD/Unit), 2019-2030
Figure 17. By Region - Global Oral Live Cholera Vaccines Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Oral Live Cholera Vaccines Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Oral Live Cholera Vaccines Revenue Market Share, 2019-2030
Figure 20. By Region - Global Oral Live Cholera Vaccines Sales Market Share, 2019-2030
Figure 21. By Country - North America Oral Live Cholera Vaccines Revenue Market Share, 2019-2030
Figure 22. By Country - North America Oral Live Cholera Vaccines Sales Market Share, 2019-2030
Figure 23. US Oral Live Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Oral Live Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Oral Live Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Oral Live Cholera Vaccines Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Oral Live Cholera Vaccines Sales Market Share, 2019-2030
Figure 28. Germany Oral Live Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 29. France Oral Live Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Oral Live Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Oral Live Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Oral Live Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Oral Live Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Oral Live Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Oral Live Cholera Vaccines Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Oral Live Cholera Vaccines Sales Market Share, 2019-2030
Figure 37. China Oral Live Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Oral Live Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Oral Live Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Oral Live Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 41. India Oral Live Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Oral Live Cholera Vaccines Revenue Market Share, 2019-2030
Figure 43. By Country - South America Oral Live Cholera Vaccines Sales Market Share, 2019-2030
Figure 44. Brazil Oral Live Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Oral Live Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Oral Live Cholera Vaccines Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Oral Live Cholera Vaccines Sales Market Share, 2019-2030
Figure 48. Turkey Oral Live Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Oral Live Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Oral Live Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Oral Live Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 52. Global Oral Live Cholera Vaccines Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Oral Live Cholera Vaccines by Region, 2023 VS 2030
Figure 54. Oral Live Cholera Vaccines Industry Value Chain
Figure 55. Marketing Channels
